002422 Sichuan Kelun Pharmaceutical
- 32.72
- +0.53+1.65%
Sichuan Kelun Pharmaceutical News
Colon Pharmaceuticals: Announcement on the results of issuing the first ultra-short-term financing notes (science and innovation notes) in 2024
Colon Pharmaceutical: Announcement on Approval of Registration of Ultra Short-Term Financing Notes and Medium-Term Notes
Colon Pharmaceutical: Announcement on the tracking rating results of “Colon Transferable Bonds”
Colon Pharmaceutical: Sichuan Colon Pharmaceutical Co., Ltd. 2023 Annual Tracking Rating Report
Colon Pharmaceutical: Announcement on “Colon Transferable Bonds” Interest Payment
Colon Pharmaceutical: Announcement on the results of the issuance of the fourth instalment of ultra-short-term financing notes (science and technology innovation notes) in 2022
Colon Pharmaceutical: Notice on not redeeming “Colon Convertible Bonds” early
Colon Pharmaceutical: An indicative announcement that Colon\'s convertible bonds may meet the redemption conditions
Colon Pharmaceutical: Announcement on the short-term transaction of senior managers' trading of the company's convertible bonds
Colon Pharmaceutical: Announcement on the results of the issuance of the third instalment of ultra-short-term financing notes (science and technology innovation notes) in 2022
Colon Pharmaceutical: Announcement on the results of issuing the second instalment of ultra-short-term financing notes in 2022
Colon Pharmaceutical: Announcement on the tracking rating results of “Colon Transferable Bonds”
Colon Pharmaceutical: Announcement of Resolutions of the First Bondholders' Meeting in 2022 on Colon Transferring Bonds
Colon Pharmaceutical: Notice on holding the first debt-holders' meeting in 2022 for Colon debt-conversion
Colon Pharmaceutical: 2021 Annual Dividend Implementation Notice
Colon Pharmaceutical: Announcement on the winning rate and priority placement results of the online issuance of convertible corporate bonds issued by Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceutical: Letter of sponsorship from Changjiang Securities Underwriting Sponsor Co., Ltd. for the public issuance of convertible corporate bonds by Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceutical: Online roadshow announcement on the public offering of convertible corporate bonds by Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceutical: 2017 Public Offering of Corporate Bonds to Qualified Investors (Phase 1) “17 Colon 01” Principal and Interest Payment and Delisting in 2022
Colon Pharmaceutical: Announcement on the results of issuing the first batch of ultra-short-term financing notes in 2022
Analysis
Price Target
No Data
No Data